Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lamb I don't think I could vote for you!

First off, I'm meaner than my picture. Secondly, don't worry as it's not a decision you'd ever have to face. I appreciate that some would consider me, but as I've posted on several occassions, it's not a position I seek. There are better candidates, though I'm confident, NONE meaner.

As for changing the BOD, unless they are willing to change themselves in the interests of shareholders and the company in general, then the only other option is for us to change it for them. Simple and as complicated as that. We have the company we deserve, and it's because of the willingness to allow it to continue. I applaud those who are willing to put in the effort and expense, and I support them.

As for your comment that if the pps were at $1.00, there would be no such talk. Well, as the saying goes, if if and and buts were candies and nuts......, or my preferred version of if Grandma had certain anatomical features, she'd be Grandpa. Simply put, we're not at $1.00, we're at 17 cents. and have been dragging along at this level or lower for most of the last 2 years. Some point to the USPTO, but that didn't seem to stop 60+ companies from paying over $200M in licensing fees after the first re-exam was filed. Nor did it cause PTSC to be in this state despite having taken in $130M plus in MMP revs. Nor did it cause us to be in this condition of turmoil as a company where we're suing our licensing partner, quarrelling with the company we bought, or paying our 5th CEO in as many years.

Time has been given and given and given. Performance over that time has proven lacking. The MMP has proven worthy, but the BOD has not. To think where they didn't before, they'll now maximize that value going forward takes a leap of faith that is unwarranted.

Share
New Message
Please login to post a reply